Last reviewed · How we verify

NCT05986006

Fusion Status After ACDF

Status unknown NA Last updated 14 August 2023
What this trial tests

NA trial testing Anterior Cervical Disc Fusion (ACDF) Surgery w/ machined bone allograft in Spine Fusion in 124 participants. Status unknown.

Timeline
7 August 2023
Primary endpoint
31 August 2024
31 August 2024

Quick facts

Lead sponsorRothman Institute Orthopaedics
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment124
Start date7 August 2023
Primary completion31 August 2024
Estimated completion31 August 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Rothman Institute Orthopaedics

Who can join

18 and older, any sex, with Spine Fusion or Spine Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pseudarthrosis, a failure of bony fusion, is one of the most common causes of revision surgery following anterior cervical discectomy and fusion (ACDF). The interbody spacer is an important component of bony fusion in ACDF, and we aim to compare machined allograft spacers versus iliac crest allograft in a randomized controlled trial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Spine Fusion

Currently open trials in the same condition.

Other Rothman Institute Orthopaedics trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05986006.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing